Bilateral Lesions in Parkinson's Disease: Gaps and Controversies
- PMID: 39726415
- PMCID: PMC11832798
- DOI: 10.1002/mds.30090
Bilateral Lesions in Parkinson's Disease: Gaps and Controversies
Abstract
Bilateral lesions of the basal ganglia using termocoagulation or radiation for improving tremor, bradykinesia, and rigidity in people with Parkinson's disease (PD) have been performed starting several decades ago, especially when levodopa and deep brain stimulation (DBS) surgery were not available. However, because of unclear additional benefit compared to unilateral lesion, and particularly to the evidence of increased adverse events occurrence, bilateral lesions were basically abandoned at the end of the 20th century. Therefore, bilateral DBS has become the standard procedure to treat PD. Magnetic resonance imaging-guided focused ultrasound (MRgFUS) is an emerging incisionless technique used to produce therapeutic brain ablation. The positive experiences of unilateral MRgFUS ablation for PD, along with the preliminary favorable outcomes of bilateral thalamic MRgFUS for essential tremor, raise the possibility to eventually reintroduce bilateral lesioning in the management of PD motor features. This possibility has so far only been tested in a few small studies. This article reviews the evidence of bilateral lesioning of the basal ganglia to treat PD, and elaborates on current gaps, controversies, and perspectives of the different available neurosurgical procedures and specifically of MRgFUS ablation. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; basal ganglia; bilateral lesions; pallidum; subthalamic nucleus; thalamus.
© 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Figures

Similar articles
-
European Academy of Neurology/Movement Disorder Society-European Section Guideline on the Treatment of Parkinson's Disease: I. Invasive Therapies.Mov Disord. 2022 Jul;37(7):1360-1374. doi: 10.1002/mds.29066. Epub 2022 Jul 6. Mov Disord. 2022. PMID: 35791767 Review.
-
European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies.Eur J Neurol. 2022 Sep;29(9):2580-2595. doi: 10.1111/ene.15386. Epub 2022 Jul 6. Eur J Neurol. 2022. PMID: 35791766
-
Unilateral Magnetic Resonance-Guided Focused Ultrasound Lesion of the Subthalamic Nucleus in Parkinson's Disease: A Prospective Study.Mov Disord. 2024 Dec;39(12):2230-2241. doi: 10.1002/mds.30020. Epub 2024 Sep 18. Mov Disord. 2024. PMID: 39295191 Free PMC article.
-
Comparison between deep brain stimulation and magnetic resonance-guided focused ultrasound in the treatment of essential tremor: a systematic review and pooled analysis of functional outcomes.J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1270-1278. doi: 10.1136/jnnp-2020-323216. Epub 2020 Oct 14. J Neurol Neurosurg Psychiatry. 2020. PMID: 33055140
-
Magnetic resonance-guided focused ultrasound thalamotomy for tremor: a report of 30 Parkinson's disease and essential tremor cases.J Neurosurg. 2018 Jan;128(1):202-210. doi: 10.3171/2016.10.JNS16758. Epub 2017 Feb 24. J Neurosurg. 2018. PMID: 28298022
Cited by
-
High-intensity focused ultrasound (HIFU) versus deep brain stimulation (DBS) for refractory tremor: team DBS.Arq Neuropsiquiatr. 2025 Jul;83(7):1-4. doi: 10.1055/s-0045-1808087. Epub 2025 Jul 6. Arq Neuropsiquiatr. 2025. PMID: 40618762 Free PMC article. Review.
-
The best of both worlds: deep brain stimulation or high-frequency focused ultrasound for tremor refractory syndromes.Arq Neuropsiquiatr. 2025 Jul;83(7):1-3. doi: 10.1055/s-0045-1808084. Epub 2025 Jul 1. Arq Neuropsiquiatr. 2025. PMID: 40592525 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical